Syndax Pharmaceuticals
Biotechnology
Syndax Pharmaceuticals is a commercial-stage biopharmaceutical company focused on oncology, with two commercially approved medicines: Revuforj (revumenib) and Niktimvo (axatilimab).
- Revuforj (revumenib)
- Niktimvo (axatilimab)
Open roles at Syndax Pharmaceuticals
1 matching role
Hybrid
New York City, New York, United States +1 more
Contract
Salary unavailable
- Medical Affairs
Posted 1 month ago
Source: Greenhouse
Showing 1 of 1 roles